Alliance Pharma PLC Share Options (3812O)
May 27 2015 - 9:00AM
UK Regulatory
TIDMAPH
RNS Number : 3812O
Alliance Pharma PLC
27 May 2015
For immediate release 27 May 2015
ALLIANCE PHARMA PLC
("Alliance" or the "Company")
Share Options
Alliance Pharma plc (AIM: APH), the speciality pharmaceutical
company, announces that on 27(th) May 2015 it awarded the following
options over ordinary shares of the Company to certain
Directors.
Name Position Number Exercise Date of Percentage
of Share price vesting of issued
Options per Share ordinary
Awarded share
capital
-------------- ----------- ---------- ----------- --------- -----------
Anthony Executive
Booley Director 146,003 43.75 May 2018 0.055
-------------- ----------- ---------- ----------- --------- -----------
Peter Executive
Butterfield Director 155,000 43.75 May 2018 0.059
-------------- ----------- ---------- ----------- --------- -----------
For further information:
Alliance Pharma plc + 44 (0) 1249 466966
John Dawson, Chief Executive
Sarah Robinson, Company Secretary
www.alliancepharma.co.uk
+ 44 (0) 20 7466
Buchanan 5000
Mark Court / Sophie Cowles
/ Jane Glover
+ 44 (0) 20 7260
Numis Securities Limited 1000
Nominated Adviser: Michael
Meade / Freddie Barnfield
Corporate Broking: David
Poutney
Notes to editors:
About Alliance
Alliance, founded in 1998, is an AIM listed speciality
pharmaceutical company based in Chippenham, Wiltshire, UK. The
Company has a strong track record of acquiring the rights to
established niche products and owns or licenses the rights to more
than 60 pharmaceutical products and continues to explore
opportunities to expand the range.
Alliance joined the AIM market of the London Stock Exchange in
December 2003 and trades under the symbol APH.
This information is provided by RNS
The company news service from the London Stock Exchange
END
RDSPKODPBBKDKPB
Alliance Pharma (LSE:APH)
Historical Stock Chart
From Apr 2024 to May 2024
Alliance Pharma (LSE:APH)
Historical Stock Chart
From May 2023 to May 2024